Connect with us

Health

Ozempic babies: Women claim weight-loss drugs are making them more fertile and experts agree

Published

on

Ozempic babies: Women claim weight-loss drugs are making them more fertile and experts agree

A new kind of baby boom could be taking place.

Some women taking GLP-1 drugs, such as Ozempic and Wegovy, have reported that they’re getting pregnant unexpectedly.

The term “Ozempic babies” has been coined on TikTok, with many women posting there about their unplanned pregnancies.

OZEMPIC, OTHER WEIGHT LOSS DRUGS MAY STRENGTHEN NEW YEAR’S RESOLUTIONS, EXPERTS SAY

This includes Michigan mom Deb Oliviara (@dkalsolive), who posted a video on Feb. 16 announcing her “Ozempic pregnancy” with her boyfriend.

Advertisement

In a conversation with Fox News Digital, Oliviara said the pregnancy was “absolutely a surprise.”

Some women are reporting unexpected pregnancies while taking Ozempic. (iStock)

“We recently moved into our dream home and just got engaged,” she said. “We were just enjoying our new life when we were surprised by a baby [boy] arriving in October.”

Oliviara has two children from a prior marriage and has been pregnant six times, including her current pregnancy, but has experienced “unidentified fertility issues.” 

“I had a first trimester loss, second trimester loss and my stillbirth,” she said. “Thankfully, this baby is super healthy.”

Advertisement

OZEMPIC AND WEGOVY WEIGHT LOSS DRUGS COULD HELP REDUCE ALCOHOL USE DISORDER SYMPTOMS, STUDY SUGGESTS

Each pregnancy changed her body, Oliviara said, which was a “reminder of the losses.”

“I spent two years in the gym about four to five days a week working out,” she said. “I worked with a health coach and a fitness coach and nothing was help[ing] me lose the last 20 pounds.” 

After her sister-in-law found weight-loss success via Wegovy, Oliviara began her own GLP-1 journey, which ended once she found out she was pregnant.

Boxes of Ozempic, an injectable antidiabetic drug, are pictured in a pharmacy. “It’s likely the main driver in the ‘Ozempic baby’ boom we’re suddenly seeing,” said one Massachusetts-based doctor.  (SEBASTIEN BOZON/AFP)

Advertisement

Dr. Angela Fitch, chief medical officer of knownwell and president of the Obesity Medicine Association, confirmed that the correlation between weight loss and fertility is “well-known.”

“It’s likely the main driver in the ‘Ozempic baby’ boom we’re suddenly seeing,” Massachusetts-based Fitch wrote in an email to Fox News Digital.

OZEMPIC, WEGOVY AND PREGNANCY RISK: WHAT YOU NEED TO KNOW ABOUT THE ISSUE

“As physicians, it’s our responsibility to emphasize the unknown and ensure that women take contraception use seriously — preferably using long-acting reversible contraception (LARC) methods, such as an IUD,” the doctor suggested.

Although the fertility effects of these drugs have not been studied extensively, Fitch said they are known to “slow gastric emptying and affect the absorption of oral medications,” including contraceptives.

Advertisement

The “main driver” of the Ozempic baby boom is the correlation between weight loss and fertility, one doctor suggested. (iStock)

Dr. Rachel McConnell, a fertility expert at Columbia University Fertility Center in New York, said she is hearing about Ozempic pregnancies “all the time.”

“I feel that patients who have obesity, or are overweight, will do much better by trying to lose weight,” she told Fox News Digital. “And there are plenty of studies to support that.”

“We encourage patients to be off the medication for at least two to three months before they even attempt conception.”

Losing weight also helps regulate a woman’s menstrual cycle, McConnell noted, which can help patients with obesity or conditions like PCOS (polycystic ovary syndrome) to get pregnant “much quicker.”

Advertisement

McConnell agreed with Fitch that GLP-1s could be decreasing the absorption of birth control medications.

OZEMPIC AND WEGOVY OVERDOSE CALLS HAVE SPIKED, EXPERTS SAY — HERE’S WHAT TO KNOW ABOUT DANGEROUS DOSES

“Not only does Ozempic work by increasing insulin, causing a decrease in glucose levels, but it also causes a slowing of emptying of the stomach,” she said.

Experts warn of ‘unknown effects’

While the possibility of there being no negative effects could be “life-changing for pregnancy-related conditions like gestational diabetes,” according to Fitch, the impact of GLP-1s on babies is unknown.

McConnell added, “Not knowing the safety of the drug, I think [patients] should be cautious and try not to get pregnant while taking it because we don’t know the long-term effects.”

Advertisement

Both doctors recommended the use of “backup barriers,” or extra contraceptives, while taking GLP-1 drugs.

Women on birth control could have a higher risk of pregnancy while taking GLP-1s like Ozempic, experts say. (iStock)

The general guidance is for pregnant women to not take Ozempic or other GLP-1s while pregnant, to prevent any potential drug toxicity to the fetus, according to McConnell.

“We encourage patients to be off the medication for at least two to three months before they even attempt conception, because it has a very long half-life of about five weeks,” she said.

OZEMPIC, THE HAPPY DRUG? STUDY SUGGESTS WEIGHT LOSS MEDICATIONS COULD REDUCE DEPRESSION, ANXIETY

Advertisement

Mom Oliviara said she wished she could have weaned herself off Ozempic instead of stopping abruptly “for the health of the baby.”

She said, “I experienced insatiable hunger. I tried to combat it by eating healthy, staying active and trying to stick with my new healthy habits I formed [while] on the GLP-1.”

The impact GLP-1s could have on babies is unknown, but the possibility of there being no negative effects could be “life-changing for pregnancy-related conditions like gestational diabetes,” a doctor said. (Jakub Porzycki/NurPhoto/Getty Images)

The expectant mother said she gained back 20 pounds within the first three months of her pregnancy, which “significantly affected” her mental health.

“I felt super uncomfortable in my body again,” she said. “I now feel like the medication is out of my system and I’ve been able to have a normal pregnancy again.”

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

She added, “We are just happy [the baby] is healthy after multiple losses.”

Oliviara said she plans to resume taking Ozempic after the baby is born.

Patients should “try not to get pregnant” while taking these drugs since side effects are unknown, a doctor advised. (iStock)

“I think it is important for people to go into it knowing it is a tool and to use it as one,” she said. “It is up to you to make the lifestyle changes for long-term results.”

Advertisement

McConnell advised other GLP-1 patients to have a plan for how to maintain their healthy lifestyles, including eating well and getting exercise, once they’ve stopped taking these medications.

GLP-1s are meant for people who “actually need weight loss” and should not be taken for fertility purposes, one doctor reminded patients. 

The doctor also reminded patients that GLP-1s are meant for people who “actually need weight loss” and should not be taken for fertility purposes.

Novo Nordisk, the maker of Ozempic and Wegovy, has created a Wegovy Pregnancy Registry to collect health data from women who take the GLP-1 medications during pregnancy.

Novo Nordisk, the maker of Ozempic and Wegovy, has created a Wegovy Pregnancy Registry to collect health data from women who take the GLP-1 medications during pregnancy. (LISELOTTE SABROE/Scanpix Denmark/AFP)

Advertisement

“The goal of the Wegovy Pregnancy Registry is to help health care providers, patients and researchers better understand the safety of Wegovy … and other weight-loss medications during pregnancy,” the registry states.

“The study collects health information on pregnant women and their babies up to 1 year of age from enrolled pregnant women themselves and the health care providers involved in their care or the care of their babies.”

The Wegovy website states that the medication “may cause fetal harm” and advises women to discontinue use if they become pregnant.

Fox News Digital reached out to Novo Nordisk for additional comment.

Advertisement

For more Health articles, visit www.foxnews.com/health.

Health

New pancreatic cancer pill could reshape treatment as early trial results stun researchers

Published

on

New pancreatic cancer pill could reshape treatment as early trial results stun researchers

NEWYou can now listen to Fox News articles!

A new drug for pancreatic cancer is showing promise in early testing.

Advertisement

Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical trial — the first time it was tested in people — to evaluate both its safety and effectiveness.

The clinical trial, led by the Dana-Farber Cancer Institute and published in The New England Journal of Medicine, tested the drug in 168 patients with advanced pancreatic cancer whose tumors had mutations in the RAS gene. All study participants had previously received at least one chemotherapy treatment.

6 THINGS TO KNOW ABOUT PANCREATIC CANCER AFTER FORMER SENATOR’S DIAGNOSIS

The drug is designed to block multiple active cancer signals that help tumor cells grow. This is especially important because more than 90% of pancreatic cancers carry these harmful mutations, researchers said.

Existing and older drugs that target RAS mutations only work on certain types that are uncommon in pancreatic cancer, such as KRAS mutations.

Advertisement

Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical trial to evaluate its safety and effectiveness. (iStock)

At the 300-milligram dose — the amount that will be used in larger phase 3 trials — about 30% of patients saw a positive response, researchers noted. Overall, about 90% of patients had their cancer either shrink or stop getting worse.

DEADLY CANCER TYPE LINKED TO OBESITY AND HIGH STRESS LEVELS

There were some side effects reported — most commonly rash, mouth inflammation, nausea and diarrhea.

Lead investigator Dr. Brian Wolpin, director of the Hale Family Center for Pancreatic Cancer Research at Dana-Farber, commented in a press release statement that this development could change the future of cancer care.

Advertisement

About 90% of patients treated with the drug experienced disease control, meaning their cancer was reduced or stabilized. (iStock)

“If supported by data from future clinical trials, daraxonrasib would be a targeted therapy relevant to nearly all patients with advanced pancreatic cancer,” he said.

RISK OF DEADLY CANCER TRIPLES WITH HIDDEN MOUTH BACTERIA, STUDY FINDS

“This trial provides the first published data showing the safety and broad activity of a RAS(ON) multi-selective inhibitor in pancreatic cancer,” Wolpin went on. “If it proves effective in larger clinical trials, it would signify a substantial shift in how this disease is treated.”

In an interview with Fox News Digital, the researcher claimed that daraxonrasib represents “one of the most promising therapy advances we’ve seen in pancreatic cancer.”

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

This is especially significant since pancreatic cancer has had “very few effective therapies” in the past, Wolpin noted.

“The study also showed disease control in approximately 90% of patients with metastatic pancreatic cancer, which is extremely exciting,” he added.

The study does not prove daraxonrasib is superior to standard treatment of chemotherapy, researchers noted. (iStock)

Wolpin noted that while side effects were common, most patients were able to tolerate treatment with “supportive care measures, and very few patients needed to stop therapy due to side effects.”

Advertisement

As this was a phase 1/2 study, it does not “definitively prove” the superiority of daraxonrasib compared to chemotherapy, Wolpin added.

CLICK HERE FOR MORE HEALTH STORIES

“The study did not include a randomized control arm that directly compared daraxonrasib with chemotherapy,” he said. “That being said, the results for daraxonrasib looked substantially better than what we have seen in prior clinical trials of chemotherapy in patients with previously treated metastatic pancreatic cancer.”

It also remains unclear how the drug may perform earlier in the disease, as the trial included patients who had already received prior treatments.

“Additional research is needed to determine how best to sequence or combine therapies to provide the most durable responses and cures,” the lead investigaror sid. (iStock)

Advertisement

For patients and families affected by pancreatic cancer, Wolpin noted that daraxonrasib signals “real momentum” toward effective treatments, but it is still investigational and is not a cure.

“Pancreatic cancer remains a challenging disease, and additional research is needed to determine how best to sequence or combine therapies to provide the most durable responses and cures,” he said.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Brian Slomovitz, director of gynecologic oncology and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, applauded this development in a separate interview with Fox News Digital.

“We are anxiously awaiting the upcoming plenary presentation of RASolute 302 at the ASCO meeting later this month,” said the expert, who was not involved in the study. “Greater than 90% of pancreatic cancers have activation of kRAS, which is a major factor in the development and progression of these cancers.” 

Advertisement

“Doubling the survival time in pretreated patients is unprecedented.”

“If the full dataset results that will be reported later this month confirm what was earlier released, I believe this will be one of the most important breakthroughs in all solid tumors,” Slomovitz went on. “Doubling the survival time in pretreated patients is unprecedented.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The doctor added that the “magnitude of benefit” could “reshape the treatment landscape” and “establish a new standard of care.”

“We will need to evaluate the full dataset for efficacy and safety,” Slomovitz added. “I am more than cautiously optimistic, and I am truly excited for our patients and their families that suffer from this dreadful disease.”

Advertisement

Continue Reading

Health

Frequent museum visits tied to reduced cellular aging, research finds

Published

on

Frequent museum visits tied to reduced cellular aging, research finds

NEWYou can now listen to Fox News articles!

People who regularly visit museums or participate in creative activities may be aging more slowly on a biological level, according to a new study from the United Kingdom.

Researchers from University College London analyzed data from more than 3,500 adults and found that people who frequently engaged in arts and cultural activities showed signs of slower biological aging in several DNA-based measurements.

The findings were published in the journal Innovation in Aging.

CREATIVE HOBBIES KEEP THE BRAIN YOUNG, STUDY FINDS — HERE ARE THE BEST ONES TO PURSUE

Advertisement

The study examined activities including painting, photography, dancing, singing, visiting museums and attending cultural events or historic sites.

People who frequently visit museums or engage in artistic activities may experience slower biological aging. (iStock)

Researchers compared participation in those activities with “epigenetic clocks,” scientific tools that examine chemical changes in DNA over time.

Adults who participated more often, and in a wider variety of activities, tended to show slower aging scores compared to people who rarely engaged in arts or cultural experiences.

ANTI-AGING BENEFITS LINKED TO ONE SURPRISING HEALTH HABIT

Advertisement

The association appeared even stronger among adults over age 40.

Researchers also noted that the effect sizes were comparable to those linked to physical activity, one of the most widely studied behaviors associated with healthy aging.

The study found that adults who engaged more often in arts and cultural activities showed slower biological aging. (iStock)

Jessica Mack, a health and wellness expert and founder of The Functional Consulting Group who was not involved in the study, said the findings reflect a growing understanding that health is influenced by more than exercise and nutrition alone.

Advertisement

“Arts and cultural engagement may be associated with slower epigenetic aging, with effects comparable in some measures to physical activity,” Mack told Fox News Digital.

She said activities such as visiting museums and engaging with music or art may help reduce stress, improve emotional regulation and increase social connection.

Experts say these activities may reduce stress, improve emotional regulation, and strengthen social connections. (iStock)

“These are not ‘extra’ lifestyle activities,” Mack said. “They may be deeply connected to how the body manages inflammation, stress hormones, mood and overall resilience.”

CLICK HERE FOR MORE LIFESTYLE STORIES

Advertisement

Mack added that people experiencing stress, social isolation, retirement or caregiving responsibilities may especially benefit from meaningful cultural engagement.

Experts cautioned, however, that the study does not prove arts engagement directly slows aging.

“This is an observational study, not an experiment,” Professor Steve Horvath of UCLA, a longevity researcher and pioneer in epigenetic aging research who was not involved in the study, told Fox News Digital.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“So when researchers find that the people who go to museums have younger epigenetic age, we cannot tell whether the museum visits slowed their aging, or whether their slower aging is what allowed them to keep visiting museums,” he said.

Advertisement

While the findings suggest a link, experts caution that the study cannot prove arts and cultural activities directly slow aging. (iStock)

Horvath said both explanations may be true to some degree, though he described the research as “methodologically careful” and worthy of further study.

The findings remained consistent even after accounting for factors such as smoking, income, body weight and other lifestyle habits.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

He added that regardless of whether arts engagement is directly slowing biological aging, staying socially and mentally active is still associated with healthier aging overall.

Advertisement

“The prescription is the same,” he said. “Keep going.”

Continue Reading

Health

Fitness influencer says one simple habit can help anyone get back in shape

Published

on

Fitness influencer says one simple habit can help anyone get back in shape

NEWYou can now listen to Fox News articles!

Fitness influencer and trainer Mark Langowski, known on social media as @bodybymark, hosted a pushup and plank competition in New York City this week, where he urged the public to get up and get moving.

On his platform of nearly two million Instagram followers, Langowski asks fit people to share their workout routines. He was able to meet more in-shape New Yorkers at his Washington Square Park meet-up, in partnership with Oikos yogurt on May 12.

A male and a female winner who achieved the most pushups or held a plank the longest were gifted $500 each.

CAN YOU HOLD A PLANK LONGER THAN OTHERS YOUR AGE? FOX HOSTS TEST THEIR CORE STRENGTH

Advertisement

Besides the cash prize, the inspiration was to get more people moving, Langowski shared during an interview with Fox News Digital.

Fitness influencer and trainer Mark Langowski, known on social media as @bodybymark, hosted a pushup and plank competition in New York City this week, where he urged the public to get up and get moving. (Kelly McGreal/Fox News Digital)

“[It’s] a way to encourage strength and overall fitness in New York City and all around the country,” he said.

“We got together and we’re doing a plank competition, pushup competition. We had a guy just do 111 pushups. We’re just getting people moving.”

FITNESS EXPERT REVEALS SIMPLE RULE TO GET IN SHAPE WITHOUT DREADING THE GYM: ‘JUST MOVE’

Advertisement

Langowski said the attributes of a great competitor include strength, humility and confidence.

“The people who … did the most, they didn’t say they were going to do the most,” he said. “And there were other people who said they could do 150, and they did 70.”

Having a bit of humility helps make a good competitor, the trainer added.

@BodybyMark films the pushup competition’s male winner during a meet-up in Washington Square Park in New York City on May 12, 2026. (Kelly McGreal/Fox News Digital)

Pushups and planks mark a “good general baseline” for measuring fitness level, according to Langowski. Some other basics include pull-ups, squats and endurance challenges, like running a mile — the kind of basics included in an elementary school fitness assessment.

Advertisement

For those who haven’t yet mastered these basics but want to get in better shape, Langowski shared some advice on how to get started.

CLICK HERE FOR MORE HEALTH STORIES

“Get with a trainer or someone who knows how to progress you,” he advised. “A lot of people are like, ‘I can’t do a pushup, so I’m never going to do one.’ That’s not the way.”

Langowski recommends starting with pushups on your knees or against a wall, then gradually progressing to standard pushups by moving onto your toes and lowering yourself fully to the ground before pushing back up.

The trainer recommends starting with pushups on your knees or against a wall, then gradually progressing to standard pushups by moving onto your toes and lowering yourself fully to the ground before pushing back up. (Milan Markovic/iStock)

Advertisement

“You’ll be surprised after you do that for a couple weeks, a couple months, a couple years – you’re going to be able to do a lot,” he said. “Nobody was born being able to do 111 pushups. They put in the work and they started somewhere.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The trainer noted that in addition to practicing, it’s just as important to give the body rest and to support muscle growth with proper protein intake and an overall healthy diet.

But perhaps the most crucial step toward getting in shape, according to Langowski, is having the motivation to get started

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

“I know that’s easy for me to say – I’ve been in fitness and been relatively fit most of my life,” he said. “And I know a lot of people are sitting on the couch and they either feel sorry for themselves or they’re going through a tough time … You’ve just got to get out there.”

The trainer noted that in addition to practicing, it’s just as important to give the body rest and to support muscle growth with proper protein intake and an overall healthy diet. (iStock)

The trainer suggested starting with a simple walk — even just around the block — with no gym equipment required.

“You don’t need an expensive gym membership to get in good shape,” he said. “Most of the people that I stop on the street, they don’t have a gym membership at all. They do it in their living room.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“And that’s where you can do the exercises I mentioned – the squats, the lunges, the pushups,” Langowski went on.

“So, I would encourage people just to start, but also to get some friends or get a trainer, someone to support you and do it safely.”

Advertisement
Continue Reading
Advertisement

Trending